At the IGTP TODAY
The CMCiB co-organised a Cafè GIPS this Wednesday focusing on the challenges and opportunities posed by alternative models to animal experimentation in biomedical research. The session brought together professionals from research, bioengineering, innovation and industry with the aim of sharing experiences and perspectives on new approaches aligned with the 3Rs framework.
IGTP has obtained funding for six projects, consolidating its trajectory in the field of biomedical and translational research on respiratory diseases. These projects, which address challenges such as tuberculosis, pulmonary fibrosis and legionellosis, represent the excellence and diversity of the research developed at the Can Ruti Campus.
A clinical trial involving 40 patients, led by IrsiCaixa and IGTP and conducted at HUGTiP, confirms that the RUTI® vaccine, owned by Archivel Farma, enhances the effectiveness of the current treatment for non-muscle-invasive bladder cancer.
In this year’s edition of #científiques, fourteen researchers from IGTP have shared their expertise in various schools and secondary schools across Catalonia, offering students a first-hand and inspiring insight into their work in biomedical research.
The Instituto de Investigación Sanitaria IGTP has secured a total of €6,518,867 for various research projects and researcher contracts within the Acción Estratégica en Salud 2024 calls.
We look back at the year's most significant news stories, showcasing the dedication and collaboration that define IGTP.
Once again, the names of around thirty renowned professionals - from the Hospital and the Germans Trias i Pujol Research Institute (IGTP), the Fight Infections Foundation, IrsiCaixa, the Josep Carreras Leukaemia Research Institute (IJC), and the Institut Català d'Oncologia (ICO) - appear on a global list of scientists who have achieved the highest impact through their publications and citations.
Researchers at IGTP and HUGTiP have reinforced their leading role in infectious disease research by characterising and developing a new study model using Drosophila, which will enable the evaluation of various infectious agents.
The European Commission has granted €2,999,101 in funding to the NanoBiCar project, coordinated by Universitat Politècnica de València, with the participation of the Germans Trias i Pujol Research Institute (IGTP). The grant falls within the EIC Pathfinder Program of the European Innovation Council (EIC), a highly competitive program aimed at identifying, developing, and scaling up breakthrough technologies and disruptive innovations.
_1728469313.jpg)
CMCiB celebrated its first five years of activity with a symposium dedicated to pioneering biomedical research at CosmoCaixa.
